insights_auto
Why is TMCI up ၂.၄၅%?
Dive Deeperchevron_right
TMCI:NASDAQ
Treace Medical Concepts, Inc
၃.၉၇ US$
arrow_upward
+၂.၄၅%(+၀.၀၉၅) 1D
အောက် ၉, GMT-၄ ၁၀:၅၉:၄၄ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TMCI...
Open
၃.၈၈ US$
High
၄.၀၇ US$
Low
၃.၈၄ US$
Mkt. cap
၂၅.၇၉ ကုဋေ
Avg. vol.
၂.၃၅ သိန်း
Volume
၅.၂၃ သောင်း
52-wk high
၇.၀၈ US$
52-wk low
၁.၁၇ US$
EPS
-၀.၉၃ US$
Beta
၁.၄၈
Shares outstanding
၆.၅၀ ကုဋေ
No. of employees
၄၅၀
Open
၃.၈၈ US$
High
၄.၀၇ US$
Low
၃.၈၄ US$
Mkt. cap
၂၅.၇၉ ကုဋေ
Avg. vol.
၂.၃၅ သိန်း
Volume
၅.၂၃ သောင်း
52-wk high
၇.၀၈ US$
52-wk low
၁.၁၇ US$
EPS
-၀.၉၃ US$
Beta
၁.၄၈
Shares outstanding
၆.၅၀ ကုဋေ
No. of employees
၄၅၀
News stories
From web sources and news partners
Benzinga
·
ပြီးခဲ့သည့် ၂ ရက်
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Profile
Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions.
In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021. Wikipedia
About Treace Medical Concepts, Inc